These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23219015)

  • 61. A history of bone marrow transplantation.
    de la Morena MT; Gatti RA
    Immunol Allergy Clin North Am; 2010 Feb; 30(1):1-15. PubMed ID: 20113883
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Update on non-myeloablative stem cell transplantation for hematologic malignancies.
    Giralt S
    Int J Hematol; 2002 Aug; 76 Suppl 1():368-75. PubMed ID: 12430884
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Induction of tumor immunity following allogeneic stem cell transplantation.
    Wu CJ; Ritz J
    Adv Immunol; 2006; 90():133-73. PubMed ID: 16730263
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Modern therapy of hematologic malignancies].
    Trnĕný M
    Cas Lek Cesk; 2001 Nov; 140(23):711-6. PubMed ID: 11787232
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hematopoietic stem cell transplantation in hematologic malignancy.
    Archuleta TD; Devetten MP; Armitage JO
    Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Relapsing hematologic malignancies after haploidentical hematopoietic stem cell transplantation.
    Hu YX; Cui Q; Liang B; Huang H
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1099-111. PubMed ID: 21440653
    [TBL] [Abstract][Full Text] [Related]  

  • 67. T-cell therapy after hematopoietic stem cell transplantation.
    Kennedy-Nasser AA; Brenner MK
    Curr Opin Hematol; 2007 Nov; 14(6):616-24. PubMed ID: 17898565
    [TBL] [Abstract][Full Text] [Related]  

  • 68. T-cell receptor specificity of CD8(+) Tregs in allotransplantation.
    Picarda E; Anegon I; Guillonneau C
    Immunotherapy; 2011 Apr; 3(4 Suppl):35-7. PubMed ID: 21524168
    [TBL] [Abstract][Full Text] [Related]  

  • 69. T-cell receptor gene transfer for treatment of leukemia.
    Heemskerk MH; Griffioen M; Falkenburg JH
    Cytotherapy; 2008; 10(2):108-15. PubMed ID: 18368589
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Indications and donor selections for allogeneic stem cell transplantation in children with hematologic malignancies.
    Handgretinger R; Kurtzberg J; Egeler RM
    Pediatr Clin North Am; 2008 Feb; 55(1):71-96, x. PubMed ID: 18242316
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Nonmyeloablative stem cell transplantation as cancer immunotherapy].
    Willems E; Baron F; Vanstraelen G; Frère P; Fillet G; Beguin Y
    Rev Med Suisse; 2005 Aug; 1(30):1973-7. PubMed ID: 16200942
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Antibody therapy for hematopoietic malignancies and cell surface antigen testing].
    Higashi K
    Rinsho Byori; 2014 Apr; 62(4):352-8. PubMed ID: 25022064
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Allergy and risk of hematologic malignancies: associations and mechanisms.
    Musolino C; Allegra A; Minciullo PL; Gangemi S
    Leuk Res; 2014 Oct; 38(10):1137-44. PubMed ID: 25171954
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Applications of next-generation sequencing to blood and marrow transplantation.
    Chapman M; Warren EH; Wu CJ
    Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S151-60. PubMed ID: 22226099
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Deeper insights into hematological oncology disorders via single-cell phospho-signaling analysis.
    Nolan GP
    Hematology Am Soc Hematol Educ Program; 2006; ():123-7, 509. PubMed ID: 17124050
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Autophagy in blood cancers: biological role and therapeutic implications.
    Nencioni A; Cea M; Montecucco F; Longo VD; Patrone F; Carella AM; Holyoake TL; Helgason GV
    Haematologica; 2013 Sep; 98(9):1335-43. PubMed ID: 24006406
    [TBL] [Abstract][Full Text] [Related]  

  • 77. T cell receptor usage in malignant diseases.
    Halapi E; Jeddi-Tehrani M; Osterborg A; Mellstedt H
    Springer Semin Immunopathol; 1999; 21(1):19-35. PubMed ID: 10389230
    [No Abstract]   [Full Text] [Related]  

  • 78. T-cell receptor repertoire usage in hematologic malignancies.
    Fozza C; Longinotti M
    Crit Rev Oncol Hematol; 2013 Jun; 86(3):201-11. PubMed ID: 23219015
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Study of the T-cell receptor repertoire by CDR3 spectratyping.
    Fozza C; Barraqueddu F; Corda G; Contini S; Virdis P; Dore F; Bonfigli S; Longinotti M
    J Immunol Methods; 2017 Jan; 440():1-11. PubMed ID: 27823906
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.